Save your place

Sign in to WhoBought

Please try again later.

Inhibikase Therapeutics, Inc. (IKT) institutional ownership

Latest close $2.23 Jul 21, 2026
Market cap$119M 52-week range SectorHealthcare
Funds holding · Q3 2023
1
reported IKT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2023
Activity unavailable N/A
0 buyers · 1 sellers

Inhibikase Therapeutics, Inc. (IKT) price and institutional activity

Dates

Q3 2023

$0 bought by 0 investors
$0 sold by 1 investors
Hamilton Lane Advisors LLC
Bought Sold Totals per quarter; hover a bar for the names.

Inhibikase Therapeutics, Inc. (IKT) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Hamilton Lane Advisors LLC · Exited
Change −14K Δ Own −100.0% Date Q3 2023
Hamilton Lane Advisors LLC Exited· Q3 2023 −14K −100.0% Q3 2023
Data through Q3 2023 · filed Q3 2023
1 of 1

Famous investor activity in Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics, Inc. (IKT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Berman Dennis N. · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Berman Dennis N. Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Canner David · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Canner David Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Kush Arvind · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Kush Arvind Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Bellini Roberto · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Bellini Roberto Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Aurentz Vincent · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Aurentz Vincent Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Munshi Amit · Director Grant (A) 155K
Owned 155K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Munshi Amit Director Grant (A) 155K 155K Jun 26, 2026 Jun 30, 2026
Aurentz Vincent · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -255K
Owned 511K Trade date Feb 21, 2026 Filed date Feb 24, 2026
Aurentz Vincent Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -255K 511K Feb 21, 2026 Feb 24, 2026
Cabell Christopher · Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -338K
Owned 677K Trade date Feb 21, 2026 Filed date Feb 24, 2026
Cabell Christopher Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -338K 677K Feb 21, 2026 Feb 24, 2026
Munshi Amit · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -19K
Owned 38K Trade date Feb 21, 2026 Filed date Feb 24, 2026
Munshi Amit Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -19K 38K Feb 21, 2026 Feb 24, 2026
Iwicki Mark T. · Director, Officer Grant (A) 5.0M
Owned 5.0M Trade date Jan 5, 2026 Filed date Jan 7, 2026
Iwicki Mark T. Director, Officer Grant (A) 5.0M 5.0M Jan 5, 2026 Jan 7, 2026
Cabell Christopher · Officer Grant (A) 900K
Owned 900K Trade date Jan 5, 2026 Filed date Jan 7, 2026
Cabell Christopher Officer Grant (A) 900K 900K Jan 5, 2026 Jan 7, 2026
McIntyre David · Officer Grant (A) 986K
Owned 986K Trade date Jan 5, 2026 Filed date Jan 7, 2026
McIntyre David Officer Grant (A) 986K 986K Jan 5, 2026 Jan 7, 2026
Sands Frank M. · 10% Owner Buy +$3.0M
Price $1.45 Qty +2.1M Owned 13.0M Trade date Nov 21, 2025 Filed date Nov 24, 2025
Sands Frank M. 10% Owner Buy $1.45 +2.1M +$3.0M 13.0M Nov 21, 2025 Nov 24, 2025
13 of 13

Inhibikase Therapeutics, Inc. (IKT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 25.0M
% of shares outstanding 15.9% Filing date Jul 17, 2026
Ra Capital Management, L.P. 25.0M 15.9% Jul 17, 2026
Sands Capital Life Sciences Pulse Fund Ii, L.P. 13.0M
% of shares outstanding 10.8% Filing date Feb 13, 2026
Sands Capital Life Sciences Pulse Fund Ii, L.P. 13.0M 10.8% Feb 13, 2026
Commodore Capital LP 14.1M
% of shares outstanding 9.9% Filing date May 15, 2026
Commodore Capital LP 14.1M 9.9% May 15, 2026
Adar1 Capital Management, LLC 13.9M
% of shares outstanding 9.9% Filing date May 15, 2026
Adar1 Capital Management, LLC 13.9M 9.9% May 15, 2026
Fairmount Funds Management LLC 12.5M
% of shares outstanding 9.9% Filing date Feb 17, 2026
Fairmount Funds Management LLC 12.5M 9.9% Feb 17, 2026
Perceptive Advisors LLC 12.6M
% of shares outstanding 8.9% Filing date May 15, 2026
Perceptive Advisors LLC 12.6M 8.9% May 15, 2026
Trails Edge Capital Partners, LP 8.1M
% of shares outstanding 6.1% Filing date May 15, 2026
Trails Edge Capital Partners, LP 8.1M 6.1% May 15, 2026
Nantahala Capital Management, LLC 7.0M
% of shares outstanding 5.7% Filing date Feb 13, 2026
Nantahala Capital Management, LLC 7.0M 5.7% Feb 13, 2026
8 of 10

Inhibikase Therapeutics, Inc. (IKT) ownership FAQ

Who owns IKT?

1 reporting institutions disclosed IKT position changes in the Q3 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.